Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Hao-Lun Luo is a leading urologic oncologist whose research centers on upper tract urothelial carcinoma (UTUC), a malignancy with exceptionally high prevalence in Taiwan. His most impactful work, the nationwide collaborative study "Segmental ureterectomy outcome of upper tract urothelial carcinoma in a high endemic area," addresses a critical gap in regional treatment evidence. By analyzing outcomes of segmental ureterectomy (SU) as an alternative to radical nephroureterectomy for selected mid- and distal ureteral tumors, Dr. Luo provides vital data supporting organ-sparing approaches in accordance with NCCN guidelines. This study, already garnering 4 citations, is foundational for clinicians managing UTUC in endemic regions where treatment paradigms must balance oncologic control with renal function preservation. Dr. Luo’s contributions extend beyond this paper; his work systematically evaluates surgical outcomes in Taiwan’s unique epidemiological context, where UTUC incidence is among the world’s highest. By generating real-world evidence from a nationwide collaborative network, he helps refine treatment algorithms for this challenging disease. His research is particularly valuable for urologists and oncologists seeking to optimize surgical decision-making in high-risk populations, demonstrating how regional data can shape global urologic oncology practice.